Prevalence of oral Candida colonization in patients with diabetes mellitus

Journal de Mycologie Medicale

Volumn 26, Issue 2, 2016, Pages 103-110

  Zomorodian, K ^a,b   Kavoosi, F ^c   Pishdad, G R ^b   Mehriar, P ^d   Ebrahimi, H ^e   Bandegani, A ^c   Pakshir, K ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Candida species; Candidiasis; Diabetes mellitus; HbA1c

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; GLUCOSE; HEMOGLOBIN A1C; ITRACONAZOLE; KETOCONAZOLE; NYSTATIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNGAL COLONIZATION; FUNGAL ISOLATE; FUNGAL PHENOMENA AND FUNCTIONS; FUNGUS IDENTIFICATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KLUYVEROMYCES MARXIANUS; MAJOR CLINICAL STUDY; MALE; MEYEROZYMA GUILLIERMONDII; MOUTH; MOUTH MUCOSA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PICHIA KUDRIAVZEVII; POLYMERASE CHAIN REACTION; POPULATION DENSITY; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; BLOOD; CANDIDIASIS, ORAL; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED;

ADULT; CANDIDA; CANDIDIASIS, ORAL; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MOUTH; PREVALENCE;

EID: 84957620760     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2015.12.008     Document Type: Article

References (46)

1. Al Mubarak S., Robert A.A., Baskaradoss J.K., Al-Zoman K., Al Sohail A., Alsuwyed A., et al. The prevalence of oral Candida infections in periodontitis patients with type 2 diabetes mellitus. J Infect Public Health 2013, 6:296-301.
2. Al-Attas S.A., Amro S.O. Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients. Ann Saudi Med 2010, 30:101-108.
3. Azimi-Nezhad M., Ghayour-Mobarhan M., Parizadeh M.R., Safarian M., Esmaeili H., Parizadeh S.M., et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J 2008, 49:571-576.
4. Belazi M., Velegraki A., Fleva A., Gidarakou I., Papanaum L., Baka D., et al. Candidal overgrowth in diabetic patients: potential predisposing factors. Mycoses 2005, 48(3):192-196.
5. Bremenkamp R.M., Caris A.R., Jorge A.O., Back-Brito G.N., Mota A.J., Balducci I., et al. Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus. Arch Oral Biol 2011, 56:549-555.
6. Budtz-Jorgensen E. Sequelae caused by wearing complete dentures. Prosthodontic treatment for edentulous patients: complete dentures and implant-supported prostheses 2004, 34-50. Mosby, St. Louis. 12th ed. G.A. Zarb, C.L. Bolender, S. Eckert, R. Jacob, A. Fenton, R. Mericske-Stem (Eds.).
7. Clinical and Laboratory Standards Institute Method for antifungal disk diffusion susceptibility testing of yeasts: approved standard 2006, Clinical and Laboratory Standards Institute; CLSI M44-A, Wayne, PA.
8. Costa C.R., de Lemos J.A., Passos X.S., de Araujo C.R., Cohen A.J., Souza L.K., et al. Species distribution and antifungal susceptibility profile of oral Candida isolates from HIV-infected patients in the antiretroviral therapy era. Mycopathologia 2006, 162:45-50.
9. Darwazeh A.M., MacFarlane T.W., McCuish A., Lamey P.J. Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. J Oral Pathol Med 1991, 20(6):280-283.
10. Ellis D., Davis S., Alexiou H., Handke R., Bartley R. Description of medical fungi 2007, Nexus Print Solutions, South Australia. 2nd ed.
11. Espinel-Ingroff A., Canton E., Gibbs D., Wang A. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole. J Clin Microbiol 2007, 45:858-864.
12. Fisher B.M., Lamey P.J., Samaranayake L.P., MacFarlane T.W., Frier B.M. Carriage of Candida species in the oral cavity in diabetic patients: relationship to glycaemic control. J Oral Pathol 1987, 16(5):282-284.
13. Goncalves R.H., Miranda E.T., Zaia J.E., Giannini M.J. Species diversity of yeast in oral colonization of insulin-treated diabetes mellitus patients. Mycopathologia 2006, 162:83-89.
14. Guggenheimer J., Moore P.A., Rossie K., Myers D., Mongelluzzo M.B., Block H.M., et al. Insulin-dependent diabetes mellitus and oral soft tissue pathologies: II. Prevalence and characteristics of Candida and Candidal lesions. Oral Surg Oral Med O 2000, 89:570-576.
15. Ieda S., Moriyama M., Takashita T., Maehara T., Imabayashi Y., Shinozaki S., et al. Molecular analysis of fungal populations in patients with oral candidiasis using internal transcribed spacer region. PLoS One 2014, 9:e101156.
16. Khosravi A.R., Yarahmadi S., Baiat M., Shokr Hi, Pourkabireh M. Factors affecting the prevalence of yeasts in the oral cavity of patients with diabetes mellitus. J Mycol Med 2008, 18:83-88.
17. Kitch T.T., Jacobs M.R., McGinnis M.R., Appelbaum P.C. Ability of RapID Yeast Plus System to identify 304 clinically significant yeasts within 5 hours. J Clin Microbiol 1996, 34:1069-1071.
18. Kumar B.V., Padshetty N.S., Bai K.Y., Rao M.S. Prevalence of Candida in the oral cavity of diabetic subjects. J Assoc Physicians India 2005, 53:599-602.
19. Lefebvre J.L., Domenge C. A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis. Oral Oncol 2002, 38:337-342.
20. Lopez-Oviedo E., Aller A.I., Martin C., Castro C., Ramirez M., Peman J.M., et al. Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method. Antimicrob Agents Chemother 2006, 50:1108-1111.
21. Lotfi-Kamran M.H., Jafari A.A., Falah-Tafti A., Tavakoli E., Falahzadeh M.H. Candidacolonization on the denture of diabetic and non-diabetic patients. Dent Res J (Isfahan) 2009, 6:23-27.
22. Lynch M.A., Brightman V.J., Greenberg M.S. Oral medicine, diagnosis and treatment 2008, JB Lippincott Co, Philadelphia. 11th ed.
23. Manfredi M., McCullough M.J., Al-Karaawi Z.M., Hurel S.J., Porter S.R. The isolation, identification and molecular analysis of Candida spp. isolated from the oral cavities of patients with diabetes mellitus. Oral Microbiol Immun 2002, 17:181-185.
24. Manfredi M., McCullough M.J., Polonelli L., Conti S., Al-Karaawi Z.M., Vescovi P., et al. In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. Oral Microbiol Immun 2006, 21:177-182.
25. Martinez R.F., Jaimes-Aveldanez A., Hernandez-Perez F., Arenas R., Miguel G.F. Oral Candida spp carriers: its prevalence in patients with type 2 diabetes mellitus. Ann Bras Dermatol 2013, 88:222-225.
26. Melton J.J., Redding S.W., Kirkpatrick W.R., Reasner C.A., Ocampo G.L., Venkatesh A., et al. Recovery of Candida dubliniensis and other Candida species from the oral cavity of subjects with periodontitis who had well-controlled and poorly controlled type 2 diabetes: a pilot study. Spec Care Dentist 2010, 30:230-234.
27. Merz W., Hay R. Medical mycology: Topley and Wilsons. Microbiology and microbial infections 2005, Edward Arnold LTD, USA. 10th ed.
28. Mirhendi H., Makimura K., Zomorodian K., Yamada T., Sugita T., Yamaguchi H. A simple PCR-RFLP method for identification and differentiation of 11 Malassezia species. J Microbiol Meth 2005, 61:281-284.
29. Mirhendi H., Makimura K., Zomorodian K., Maeda N., Ohshima T., Yamaguchi H. Differentiation of Candida albicans and Candida dubliniensis using a single-enzyme PCR-RFLP method. Jpn J Infec Dis 2005, 58:235-237.
30. Mirhendi H., Makimura K., Khoramizadeh M., Yamaguchi H. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Jpn J Med Mycol 2006, 47:225-229.
31. Motta-Silva A.C., Aleva N.A., Chavasco J.K., Armond M.C., Franca J.P., Pereira L.J. Erythematous oral candidiasis in patients with controlled type II diabetes mellitus and complete dentures. Mycopathologia 2010, 169:215-223.
32. Odds F.C. Candida and candidosis 1988, 68-92. BailliereTindall, London. 2nd ed.
33. Odds F.C., Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994, 32:1923-1929.
34. Odds F.C., Evans E.G., Taylor M.A., Wales J.K. Prevalence of pathogenic yeasts and humoral antibodies to Candida in diabetic patients. J Clin Pathol 1978, 31:840-844.
35. Pinjon E., Moran G.P., Coleman D.C., Sullivan D.J. Azole susceptibility and resistance in Candida dubliniensis. Biochem Soc T 2005, 33:1210-1214.
36. Premkumar J., Ramani P., Chandrasekar T., Natesan A., Premkumar P. Detection of species diversity in oral Candida colonization and anti-fungal susceptibility among non-oral habit adult diabetic patients. J Nat Sci Biol Med 2014, 5:148-154.
37. Sahin I., Oksuz S., Sencan I., Gulcan A., Karabay O., Gulcan E., et al. Prevalance and risk factors for yeast colonization in adult diabetic patients. Ethiopian Med J 2005, 43:103-109.
38. Shah S.C., Malone J.I., Harvey C. Glycosylated hemoglobin colorimetric vs chromatographic measurement. Diabetes Res 1986, 3:381-386.
39. Shenoy M.P., Puranik R.S., Vanaki S.S., Puranik S.R., Shetty P., Shenoy R.A. A comparative study of oral candidal species carriage in patients with type 1 and type 2 diabetes mellitus. J Oral Maxillofac Pathol 2014, 18:60-65.
40. Soysa N.S., Samaranayake L.P., Ellepola A.N. Diabetes mellitus as a contributory factor in oral candidosis. Diabetic Med 2006, 23:455-459.
41. Swinne D., Watelle M., Nolard N. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non-Candida albicans yeast isolates. Rev Iberoamericana Micol 2005, 22:24-28.
42. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969, 6:24-27.
43. Willis A.M., Coulter W.A., Fulton C.R., Hayes J.R., Bell P.M., Lamey P.J. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabetic Med 1999, 16:675-679.
44. Xu J., Mitchell T.G. Geographical differences in human oral yeast flora. Clin Infect Dis 2003, 36:221-224.
45. Yarahmadi S.H., Khosravi A.R., Larijani B., Baiat M., Mahmoudi M., Baradarjalili R. Assessment of the fungal flora and the prevalence of fungal infections in the mouth of diabetics. Irn J Endcorinol Metab 2002, 4:105-109.
46. Zeini F., Mahbod A., Emami M. Comprehensive Medical Mycology 2009, University of Tehran Press. 3rd Ed.